-+ 0.00%
-+ 0.00%
-+ 0.00%

KAILERA THERAPEUTICS INC: ADVANCING KAI-7535 IN A GLOBAL PHASE 2 CLINICAL TRIAL IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT

Reuters·07/07/2026 11:00:04

Please log in to view news